- Lauren Rackow / Cahill Gordon & Reindel LLP
- Robin Feldman / UC Hastings College of Law
- Schonette Jones Walker / Office of the Attorney General – Maryland
- Matthew Kent / Alston & Bird LLP
- Brian Sher / CMS UK
Presented by the Health Care and Pharmaceuticals Committee.
“More Spring Blooms”
Rising prices for prescription drugs have spawned a raft of antitrust cases and regulatory inquiries on both sides of the Atlantic. But can and should antitrust laws be used to deal with the issue of high drug prices? This session will consider the use of antitrust litigation and legislative efforts in the U.S. and Europe to address perceived market failures in the pharmaceutical arena.